Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

SCSHP Annual Meeting 2022 (Virtual Conference)


SCSHP 2022 Annual Meeting
Thursday, March 3 - Friday March 4, 2022
 
To register and view the full meeting agenda, visit https://scshp.com/meetinginfo.php
 
Location:  Online Virtual Platform 
 
For all continuing education session details, including speakers and learning objectives, please expand the individual sessions below! 
 

Date: Mar 3, 2022 08:00 AM - Mar 4, 2022 05:30 PM

CE Hours

12.50

CE Units

1.250

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

SCSHP

Requirements for CE Credit

In order to claim credit and have CE credit submitted to the CPE Monitor, participants must complete the following steps within 60 days of the event.  Completion of these steps within 30 days of the event will allow for any issues in transmission to NABP to be rectified by our office. The CPE Monitor will not accept credit that is submitted greater than 60 days after the event per NABP policy.
  1. Check in upon arrival at the meeting
  2. Complete the online program evaluations
  3. Provide the correct month and day of birth and NABP e-Profile ID.  Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.  

 

 

 

 

At the completion of this activity, the pharmacist will be able to:
  1. Explain the mechanism of SGLT2i for CKD
  2. Critically evaluate the published literature of renal outcomes regarding SGLT2i for CKD
  3. Formulate a person-centered treatment plan with monitoring parameters for CKD
At the completion of this activity, the pharmacy technician will be able to:
  1. Explain the mechanism of SGLT2i for CKD
  2. Summarize a potential benefit and risk of SGLT2i on renal outcomes for CKD
  3. Determine appropriate counseling points with a SGLT2i for a person with CKD

Speaker(s)/Author(s)

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor and Director of Pharmacy Education, University of South Carolina College of Pharmacy

Activity Number

0062-9999-22-065-L01-P/T
Date: 03/03/22
Time: 09:30 AM - 10:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Distinguish between professional and personal CGMs 
  2. Describe the characteristics of the different professional CGMs on the market
  3. Define the role of a pharmacist in the implementation and interpretation of professional CGMs
  4. Evaluate the effectiveness of professional CGMs in diabetes management

Speaker(s)/Author(s)

Aly York, PharmD
PGY1 Outpatient Pharmacy Resident, Prisma Health Richland

Lawrence Bean, PharmD
PGY1 Outpatient Pharmacy Resident, Prisma Health Richland

Activity Number

0062-9999-22-066-L01-P/T
Date: 03/03/22
Time: 11:00 AM - 12:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Activity Number

0062-9999-22-067-L01-P/T
Date: 03/03/22
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Discuss emerging research outcomes from throughout the state of South Carolina
  2. Recognize novel ideas for research and quality initiative projects in your pharmacy practice areas
  3. Review pivotal results from local investigations across the state of South Carolina

Speaker(s)/Author(s)

Carly Huggins, PharmD Candidate 2022
University of South Carolina College of Pharmacy

Gadison Quick, PharmD
PGY2 Internal Medicine Pharmacy Resident, Prisma Health Richland Hospital

Rachel Robinson, PharmD Candidate
Presbyterian College School of Pharmacy

Activity Number

0062-9999-22-068-L01-P/T
Date: 03/03/22
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Activity Number

0062-9999-22-069-L01-P/T
Date: 03/03/22
Time: 03:30 PM - 04:00 PM

CE Hours

0.50
 

 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Differentiate between the types of heart failure (HF)
  2. Describe the pathophysiology of HF
  3. Examine the historical pharmacologic management of Heart failure with preserved ejection fraction (HFpEF)
  4. Analyze recent primary literature related to the management of HFpEF
  5. Develop a treatment plan with monitoring when given a patient scenario with HFpEF

Speaker(s)/Author(s)

Katy Wolfe, PharmD
PGY1 Pharmacy Resident, Spartanburg Medical Center

Sanyia Khan, PharmD
CVICU Clinical Specialist, Spartanburg Medical Center

Activity Number

0062-9999-22-070-L01-P/T
Date: 03/04/22
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Summarize the efficacy and safety of cabotegravir/rilpivirine long-acting injectable for HIV treatment
  2. Describe the workflow of implementing cabotegravir/rilpivirine long-acting injectable into real-world practice
  3. Apply current recommendations regarding cabotegravir/rilpivirine long-acting injectable for the treatment of HIV

Speaker(s)/Author(s)

Morgan Pizzuti, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health - Richland, University of South Carolina

Y. Vivian Tsai, PharmD
Infectious Diseases Clinical Pharmacy Fellow, Prisma Health Richland - University of South Carolina

Activity Number

0062-9999-22-071-L02-P/T
Date: 03/04/22
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe the pathophysiology and clinical presentation of diabetic ketoacidosis (DKA)
  2. Identify electrolyte disturbances often associated with DKA
  3. Review treatment guidelines for DKA
  4. Evaluate recent literature for selection of IV fluids in treatment of DKA
  5. Define euglycemic DKA and the risks associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe the presentation of diabetic ketoacidosis (DKA)
  2. Identify electrolyte disturbances often associated with DKA
  3. Recognize therapeutic options for DKA

Speaker(s)/Author(s)

Amanda Guffey, PharmD, BCCCP, BCPS
Clinical Pharmacist – Critical Care, Lexington Medical Center

Activity Number

0062-9999-22-072-L01-P/T
Date: 03/04/22
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe the role of antiplatelets in the pathophysiology of coronary artery disease
  2. Assess patient-specific characteristics, including ischemic and bleeding risks, to evaluate selection of antiplatelet management
  3. Examine guidelines and clinical trial recommendations for P2Y12 inhibitor selection, duration, and dose in acute coronary syndromes
  4. Develop an individualized, patient-center approach regarding antiplatelet management in coronary artery disease
At the completion of this activity, the pharmacy technician will be able to:
  1. Describe the role of antiplatelets in the pathophysiology of coronary artery disease
  2. Recognize patient-specific characteristics that impact the selection of antiplatelet management
  3. Discuss the role of shared decision making in the treatment of coronary artery disease

Speaker(s)/Author(s)

Ashley Costello, PharmD, BCPS
Clinical Pharmacist, Self Regional Healthcare

Activity Number

0062-9999-22-073-L01-P/T
Date: 03/04/22
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Review the microbiology, pathogenicity, and common mechanisms of resistance of Pseudomonas aeruginosa
  2. List the typical antibiotics utilized to treat Pseudomonas infections
  3. Evaluate the guidelines and other literature surrounding the treatment of Pseudomonas infections

Speaker(s)/Author(s)

Michael K. Shaw, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Activity Number

0062-9999-22-074-L01-P/T
Date: 03/04/22
Time: 12:15 PM - 12:45 PM

CE Hours

0.50
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Describe mechanisms of action and mechanisms of resistance to new antimicrobial agents including eravacycline, imipenem/cilastatin/relebactam, and cefiderocol
  2. Evaluate in vitro literature for these agents as well as clinical trials
  3. Select an antimicrobial agent based on resistance patterns, type of infection, and strength of clinical evidence
At the completion of this activity, the pharmacy technician will be able to:
  1. Recall the mechanisms of action and mechanisms of resistance to new antimicrobial agents
  2. Recognize pharmacologic management strategies for resistant microbial infections

Speaker(s)/Author(s)

Kelli R. Keats, PharmD, MPA, BCCCP
Critical Care Pharmacist – Medical ICU, Augusta University Medical Center

Activity Number

0062-9999-22-075-L01-P/T
Date: 03/04/22
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist and pharmacy technician will be able to:
  1. Evaluate the difference between major and non-major bleeding
  2. Summarize current pharmacological interventions for antithrombotic reversal
  3. Demonstrate understanding of antithrombotic reversal agent mechanisms of action
  4. Review literature regarding controversies related to antithrombotic reversal

Speaker(s)/Author(s)

Katrina Phelps, PharmD
PGY1 Pharmacy Resident, Bon Secours St. Francis Downtown

Activity Number

0062-9999-22-076-L01-P/T
Date: 03/04/22
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Compare and contrast eligibility criteria for thrombolytic therapy in acute ischemic stroke patients on the basis of emerging literature
  2. Interpret the role and supporting evidence behind tenecteplase as an alternative to traditional thrombolytic treatment of stroke
  3. Describe endovascular treatments for ischemic stroke, indications for use, eligibility of patients, and the concomitant use of thrombolytics
  4. Develop treatment recommendations incorporating appropriate diagnostic modalities for a patient presenting with stroke-like symptoms
At the completion of this activity, the pharmacy technician will be able to:
  1. List common eligibility criteria for thrombolytic therapy in acute ischemic stroke
  2. Describe the dosing and administration of tenecteplase for stroke treatment
  3. Recognize non-pharmacologic treatments for ischemic stroke and the role for thrombolysis in patients undergoing endovascular therapies
  4. Outline treatment recommendations for the management of acute ischemic stroke

Speaker(s)/Author(s)

Charles “Trey” Wingerson III, PharmD
Assistant Professor, Presbyterian College School of Pharmacy

Jimmy L. Pruitt III, PharmD, BCPS
Emergency Medicine Clinical Pharmacy Specialist

Activity Number

0062-9999-22-077-L01-P/T
Date: 03/04/22
Time: 04:00 PM - 05:30 PM

CE Hours

1.50